Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/27/1997WO1997044330A1 Process for preparing biologically active derivatives of 1,2,4-triazol and intermediaries useful in this process
11/27/1997WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997WO1997044326A1 Aryl pyrimidine derivatives
11/27/1997WO1997044324A1 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
11/27/1997WO1997044322A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997WO1997044321A1 Antagonists of gonadotropin releasing hormone
11/27/1997WO1997044315A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997WO1997044306A1 Chalcone derivatives and drugs containing the same
11/27/1997WO1997044063A2 Dha-pharmaceutical agent conjugates
11/27/1997WO1997044062A1 The use of 5-ht1b/1d agonists to treat ocular pain
11/27/1997WO1997044058A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997WO1997044056A1 Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
11/27/1997WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997WO1997044051A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
11/27/1997WO1997044048A1 Cosmetic compositions
11/27/1997WO1997044047A1 Composition and method for treating herpes simplex
11/27/1997WO1997044045A1 Malatonin in combination with analgesics
11/27/1997WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997WO1997044043A1 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)
11/27/1997WO1997044042A1 Sleep quality improvement using a growth hormone secretagogue
11/27/1997WO1997044041A1 Antagonists of gonadotropin releasing hormone
11/27/1997WO1997044040A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
11/27/1997WO1997044039A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/27/1997WO1997044038A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997WO1997044037A1 Antagonists of gonadotropin releasing hormone
11/27/1997WO1997044036A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997WO1997044035A1 Methods of treating hypertension
11/27/1997WO1997044034A1 Remedy for rosacea
11/27/1997WO1997044033A1 Non-peptide g-csf mimetics
11/27/1997WO1997044032A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics
11/27/1997WO1997044031A1 Agent for treating allergic dermatitis
11/27/1997WO1997044030A1 Use of substituted azaspirane in the treatment of asthma
11/27/1997WO1997044029A1 Methods of increasing nitric oxide synthesis
11/27/1997WO1997044028A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
11/27/1997WO1997044027A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
11/27/1997WO1997044026A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
11/27/1997WO1997044025A1 Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil
11/27/1997WO1997044024A1 Novel arachidonic acid metabolite, 16-hete
11/27/1997WO1997044023A1 Pharmaceutical compositions based on diclofenac
11/27/1997WO1997044022A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
11/27/1997WO1997044021A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
11/27/1997WO1997044020A1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
11/27/1997WO1997044019A1 Inhibitor of ceramidase
11/27/1997WO1997044018A1 Dermal compositions comprising acrylate polymers, nicotine and low-swell clay
11/27/1997WO1997044017A1 Effervescent bisphosphonate formulation
11/27/1997WO1997044015A1 Microparticles and their use in wound therapy
11/27/1997WO1997044014A1 Antifungal compositions with improved bioavailability
11/27/1997WO1997044013A1 Aerodynamically light particles for pulmonary drug delivery
11/27/1997WO1997044007A2 A barrier cream comprising hexamethylenetetramine or derivative thereof
11/27/1997WO1997044006A1 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials
11/27/1997WO1997044000A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
11/27/1997WO1997043902A1 Use of gaba uptake inhibitors as anti-tussive agents
11/27/1997WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997WO1997035573A3 Nsaids in the treatment of pruritus
11/27/1997WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997DE19622457A1 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 7alpha- (5-Methylaminopentyl) -estratriene, processes for their preparation, pharmaceutical compositions containing these 7alpha- (5-Methylaminopentyl) -estratriene and their use for the preparation of medicaments
11/27/1997DE19621177A1 Kohlenhydratderivate und ihre Synthese an fester Phase Carbohydrate derivatives and their synthesis on solid phase
11/27/1997DE19621038A1 Aminoguanidine, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten Aminoguanidines, processes for their preparation and pharmaceutical compositions containing these compounds
11/27/1997DE19620644A1 Verwendung von stickstoffhaltigen Komplexbildnern zur Desodorierung und antimikrobiellen Behandlung der Haut und textilen Fasermaterialien The use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and of textile fiber materials
11/27/1997DE19620341A1 Medicine for treating geriatric complaints by percutaneous resorption
11/27/1997CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997CA2256578A1 Novel arachidonic acid metabolite, 16-hete
11/27/1997CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997CA2256465A1 Blocking expression of virulence factors in s. aureus
11/27/1997CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same
11/27/1997CA2255910A1 Methods of treating hypertension
11/27/1997CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997CA2255838A1 Melatonin in combination with analgesics
11/27/1997CA2255792A1 Methods of increasing nitric oxide synthesis
11/27/1997CA2255731A1 Non-peptide g-csf mimetics
11/27/1997CA2255705A1 Aryl pyrimidine derivatives
11/27/1997CA2255650A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997CA2255541A1 Synthetic glucagon binding proteins
11/27/1997CA2254974A1 Antagonists of gonadotropin releasing hormone
11/27/1997CA2254769A1 Antagonists of gonadotropin releasing hormone
11/27/1997CA2254768A1 Antagonists of gonadotropin releasing hormone
11/27/1997CA2254756A1 Antagonists of gonadotropin releasing hormone
11/27/1997CA2254121A1 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
11/27/1997CA2253934A1 Inhibitors of protein farnesyl transferase
11/27/1997CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997CA2253541A1 Human phospholipase inhibitor
11/27/1997CA2253459A1 A barrier cream comprising hexamethylenetetramine or derivative thereof
11/27/1997CA2253342A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997CA2253217A1 Use of substituted azaspirane in the treatment of asthma
11/27/1997CA2252537A1 Benzofuran carboxamides and their therapeutic use
11/27/1997CA2252531A1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997CA2252501A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
11/27/1997CA2227171A1 Icea gene and related methods
11/26/1997EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/26/1997EP0808844A2 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells
11/26/1997EP0808843A2 Novel macrolide compound 0406
11/26/1997EP0808838A1 Sulfur-containing heterocyclic bradykinin antagonists, processes for their production and use thereof
11/26/1997EP0808833A2 Vitamin D3 analogs
11/26/1997EP0808832A2 Fluorinated vitamin D3 analogs
1 ... 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 ... 7860